about
Subversion of Host Innate Immunity by Uropathogenic Escherichia coliUrinary Tract Infection: Pathogenesis and Outlook.Morphological plasticity promotes resistance to phagocyte killing of uropathogenic Escherichia coliComponents of SurA required for outer membrane biogenesis in uropathogenic Escherichia coli.Antibody responses and protection from pyelonephritis following vaccination with purified Escherichia coli PapDG protein.Virulence gene expression in human community-acquired Staphylococcus aureus infection.Suppression of bladder epithelial cytokine responses by uropathogenic Escherichia coli.Periplasmic peptidyl prolyl cis-trans isomerases are not essential for viability, but SurA is required for pilus biogenesis in Escherichia colicontribution of genetically restricted, methicillin-susceptible strains to the ongoing epidemic of community-acquired Staphylococcus aureus infections.Bacterial lysis liberates the neutrophil migration suppressor YbcL from the periplasm of uropathogenic Escherichia coliThe natural history of contemporary Staphylococcus aureus nasal colonization in community children.Attenuation of human neutrophil migration and function by uropathogenic bacteria.Maturation of intracellular Escherichia coli communities requires SurA.Cathelicidin augments epithelial receptivity and pathogenesis in experimental Escherichia coli cystitis.Molecular Epidemiology of Recurrent Cutaneous Methicillin-Resistant Staphylococcus aureus Infections in Children.Vitamin D sufficiency and Staphylococcus aureus infection in children.Preparation and in vitro antimicrobial activity of silver-bearing degradable polymeric nanoparticles of polyphosphoester-block-poly(L-lactide).UPEC hemolysin: more than just for making holes.Synthetic polymer nanoparticles conjugated with FimH(A) from E. coli pili to emulate the bacterial mode of epithelial internalization.Imidazolium salts as small-molecule urinary bladder exfoliants in a murine model.Interaction of uropathogenic Escherichia coli with host uroepithelium.A Murine Model for Escherichia coli Urinary Tract Infection.Klebsiella pneumoniae FimK Promotes Virulence in Murine Pneumonia.Local Generation of Kynurenines Mediates Inhibition of Neutrophil Chemotaxis by Uropathogenic Escherichia coli.A serologic correlate of protective immunity against community-onset Staphylococcus aureus infection.OmpA of uropathogenic Escherichia coli promotes postinvasion pathogenesis of cystitis.Quantitative assessment of human neutrophil migration across a cultured bladder epitheliumIntracellular lifestyles and immune evasion strategies of uropathogenic Escherichia coli.Synthesis, characterization, in vitro SAR and in vivo evaluation of N,N'bisnaphthylmethyl 2-alkyl substituted imidazolium salts against NSCLC.Polymeric nanoparticles in development for treatment of pulmonary infectious diseases.CD14- and Toll-like receptor-dependent activation of bladder epithelial cells by lipopolysaccharide and type 1 piliated Escherichia coli.Renal scar formation and kidney function following antibiotic-treated murine pyelonephritis.A Newborn With Hydrops, Hydrocephalus, and Ophthalmologic Abnormalities.Management of pancreatic carcinoma.Shell crosslinked nanoparticles carrying silver antimicrobials as therapeutics.Oseltamivir dosing in premature infants.A second target of the antimalarial and antibacterial agent fosmidomycin revealed by cellular metabolic profiling.High Levels of Cyclic Di-GMP in Klebsiella pneumoniae Attenuate Virulence in the Lung.Salmonella ovarian abscess in an adolescent.Scurvy revealed by difficulty walking: three cases in young children.
P50
Q26770272-CD062101-FF4E-4EAA-BA74-895B51AC55DCQ30244953-DC6EC823-12B2-4F49-9DAA-6926E7826518Q30499366-E15DCB22-7BCE-4955-8D95-ED6418589DBAQ33374005-46A022C0-6069-4241-AEE0-4A0DC1E2B55EQ33727198-0EB402DE-64C0-44E8-A193-144A965DF620Q33744296-788D9764-4EB6-49C5-9C12-71828DBAD2EEQ33883358-43BD4EB0-5224-4E5C-9867-95BDBF93B681Q34124391-96676428-EF1A-4895-A261-D966D12383FDQ34245797-02E0D9D6-6B2F-4D24-99AE-6B5430595F76Q34595898-EBA50FB9-6898-4312-8BE0-F04D96AE76E9Q34802718-FF89CE33-919C-4FE7-9147-A077DE0C2449Q34975465-9D03AD94-B774-4F3C-880F-88864A8FC9DBQ34975776-FFDC636A-1CD1-4F0A-82AB-4953E7ADF579Q35197365-C4648DBC-C550-48BB-8029-7634C103B9DDQ35239269-4CBB0F09-E44E-4217-96C4-B6845D2F059DQ35449667-362E2398-9612-426A-8268-E8D6FC130A7DQ35684310-1DF1A15E-FA0F-45E8-A71A-FDAC1D16A5F8Q35700993-D2595B7E-B893-452A-8871-34B627FFDE8EQ35887488-797E6324-C8BF-4D0B-9236-D5FB365F3694Q35960915-BE3F18E2-37BB-49CC-97A3-2E7286ECED23Q36032368-ADE94606-1D6F-4015-B52C-89C9CF70E750Q36219597-9E700831-4B51-45F5-94DF-A67BA92A8946Q36487863-8E05D391-13CF-416C-924E-50E8ABCF3A1EQ36728035-FB0DD5F6-4D99-439A-BA99-702533C60186Q36811244-1B7970A6-1EEB-456F-A90A-2D38DAD0F1F0Q37451212-4904D034-C977-41C5-AAD0-75C4F2847A03Q37602461-55833E01-C3A5-41EF-A1E8-FE26CEB504F6Q37786336-80671ED0-924D-4B16-89D4-DB9C77847191Q38719273-2642B371-958B-4B1E-8921-4A8D09A3D1FBQ38789348-34BC6816-C534-45BE-AA74-9875549D285CQ39730257-D8728ED6-BCF6-40BD-A3BC-D694CECBB137Q40061790-362933C4-4D4A-499C-9AA1-E4E2251A9082Q40261025-13506152-9AF0-49CF-90FE-7636B8642729Q40408243-28CC9391-C1F6-410E-ABF8-A9F54A6EC8BBQ41871547-C84AF02F-CAD6-4AF1-99D8-E5F3D4249F36Q41890159-9082E0BC-B983-4CFA-B1EB-29C43660B7A6Q42722311-E269C41F-B334-4FED-B753-23225F0D339CQ47705216-7A809A82-9AF1-4712-9A70-FE828B6FC309Q50071679-EDEF95D9-B584-4423-A721-41D9D33C0B80Q50306866-443AADB8-6C57-402D-BD52-69407359FB70
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
David A. Hunstad
@ast
David A. Hunstad
@en
David A. Hunstad
@es
David A. Hunstad
@nl
David A. Hunstad
@sl
type
label
David A. Hunstad
@ast
David A. Hunstad
@en
David A. Hunstad
@es
David A. Hunstad
@nl
David A. Hunstad
@sl
prefLabel
David A. Hunstad
@ast
David A. Hunstad
@en
David A. Hunstad
@es
David A. Hunstad
@nl
David A. Hunstad
@sl
P106
P1153
56068540600
P21
P31
P496
0000-0002-9848-0975